Health-related quality of life and long-term mortality in patients treated with percutaneous coronary intervention
American Heart Journal , Volume 159 - Issue 3 p. 471- 476
Background: Health status has become increasingly important as an outcome measure in patients with cardiovascular disease. Poor patient-rated health status has been shown to predict mortality in patients with coronary artery disease and heart failure. In patients treated with percutaneous coronary intervention (PCI), we examined whether poor health status predicts 6-year mortality and whether a decline in health status is associated with adverse clinical outcome. Methods: Consecutive patients (N = 872) treated with PCI as part of the RESEARCH registry, completed the 36-item Short-Form Health Survey (SF-36) at 1 and 12 months post-PCI. Results: The SF-36 domains physical functioning (hazard ratio [HR] 2.59, 95% CI 1.61-4.16), social functioning (HR 2.76, 95% CI 1.74-4.37), role limitations due to physical functioning (HR 2.45, CI 1.52-3.92), mental health (HR 2.12, 95% CI 1.35-3.31), vitality (HR 1.73, 95% CI 1.09-2.74), bodily pain (HR 2.25, 95% CI 1.43-3.54), and general health (HR 2.46, 95% CI 1.57-3.87) were associated with 6-year mortality. A decline in health status was not related with higher 6-year mortality. Conclusions: Health status domains as measured with the SF-36 predicted death at 6-year follow-up in PCI patients treated with drug-eluting stenting, independent of demographic and clinical characteristics. In contrast, a decline in health status between 1 and 12 months post index procedure, as measured with the SF-36, was not associated with 6-year mortality in PCI patients treated with drug-eluting stenting.
|Short Form 36, adult, article, bare metal stent, controlled study, coronary artery disease, disease registry, drug eluting stent, female, hazard ratio, health care policy, health status, human, long term care, major clinical study, male, mental health, mortality, pain, patient care, percutaneous coronary intervention, physical capacity, priority journal, quality of life, rapamycin, social interaction, treatment outcome|
|American Heart Journal|
|Organisation||Erasmus MC: University Medical Center Rotterdam|
Schenkeveld, L, Pedersen, S.S, van Nierop, J.W.I, Lenzen, M.J, de Jaegere, P.P.T, Serruys, P.W.J.C, & van Domburg, R.T. (2010). Health-related quality of life and long-term mortality in patients treated with percutaneous coronary intervention. American Heart Journal, 159(3), 471–476. doi:10.1016/j.ahj.2009.12.012